Breast Cancer Clinical Trials in Albuquerque, NM

Breast Cancer Clinical Trials in Albuquerque, NM

View the best 10 breast cancer medical studies in Albuquerque, New Mexico. Access promising new therapies by applying to a Albuquerque-based Breast Cancer clinical trial.

Trials in Albuquerque, New Mexico

Here are the top 10 medical studies for breast cancer in Albuquerque, New Mexico

Image of GSK Investigational Site in Skokie, United States.

Placebo +1 More

Chemotherapy

Recruiting1 awardPhase 3
This trial is testing Niraparib, a drug that stops cancer cells from fixing their broken DNA, in patients with certain types of breast cancer that are either genetically aggressive or have signs of remaining disease after treatment. Niraparib is a drug already used for ovarian cancer and has shown promise in treating breast cancer with certain genetic markers.
Image of Montefiore Medical Center - Moses Campus in Bronx, United States.

FSRS +1 More

Radiation Therapy

Recruiting1 award
This trial evaluates if a lower radiation dose over multiple days reduces side effects vs. one day of full radiation dose for cancer patients on immunotherapy.
Image of St. Bernards Medical Center in Jonesboro, United States.

Imlunestrant

Selective Estrogen Receptor Downregulator (SERD)

Recruiting2 awardsPhase 3
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Image of Cedars Sinai Medical Centre in Los Angeles, United States.

Endocrine therapy interruption

Recruiting1 award15 criteria
This trial is investigating whether or not temporarily interrupting endocrine therapy, in order to allow pregnancy, increases the risk of breast cancer recurrence. The study will also evaluate different indicators related to fertility, pregnancy, and breast cancer biology.
Image of Cedars Sinai Medical Center in Los Angeles, United States.

Paclitaxel +3 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing whether adding the drug pembrolizumab to a standard treatment regimen for HER2-positive breast cancer improves outcomes.
Image of Research Site in Farmington, United States.

Camizestrant

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3
This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.
Image of Research Site in Jonesboro, United States.

Durvalumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial tests the effectiveness and safety of new treatments for TNBC and hormone receptor-low/HER2-negative breast cancer.
Image of Research Site in Columbus, United States.

Camizestrant

Recruiting2 awardsPhase 3
This trial studies if a new drug can help improve outcomes for breast cancer patients with a high risk of recurrence. Treatment lasts 7 years.
Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Carboplatin +3 More

Chemotherapy

Recruiting4 awardsPhase 3
This trial is studying a combination of drugs given with or without hormone therapy to see how well they work in treating patients with hormone receptor-positive, HER2-positive breast cancer.
Image of Regional Medical Center in Anniston, United States.

Paclitaxel +2 More

Taxane

Recruiting2 awardsPhase 3
This trial is comparing two different chemotherapy regimens to see which is more effective in treating patients with stage I-III breast cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.